NCT04483115View on ClinicalTrials.gov

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

June 29, 2022

Study Completion Date

June 29, 2022

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

TPN171H

Tablets; Oral; Single dose

DRUG

Placebo

Tablets; Oral; Single dose

DRUG

Tadalafil

Tablets; Oral; Single dose

Trial Locations (9)

100032

Peking Union Medical College Hospital, Beijing

100034

Peking University First Hospital, Beijing

100037

Fuwai Hospital CAMS&PUMC, Beijing

200433

Shanghai Pulmonary Hospital, Shanghai

341000

First Affiliated Hospital Of Gannan Medical University, Ganzhou

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

410011

The Second Xiangya Hospital of Central South University, Changsha

430030

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan

730000

Gansu Provincial Hospital, Lanzhou

All Listed Sponsors
collaborator

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OTHER

lead

Vigonvita Life Sciences

INDUSTRY

NCT04483115 - Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter